Associations of child-to-adult body size change with risk of hypertension and metabolic dysfunction-associated steatotic liver disease: a population-based cohort study of 226,420 individuals
Open Access
- 2 September 2025
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 25 (1) , 1-13
Abstract
The relationships between body size changes and the risk of hypertension and metabolic dysfunction-associated steatotic liver disease (MASLD) are still unclear. This study examined the independent and combined influences of child and adult body size on the risk of adulthood hypertension and MASLD. We included 226,420 participants from the UK Biobank who were free of hypertension and liver diseases. Child-to-adult body size categories were identified based on self-reported childhood body size and measured BMI in adulthood. Cox proportional hazard regression models were applied to assess the associations between body size categories and the incidence of hypertension and MASLD. Mediation analyses to address the effect of anthropometric measures and metabolic risk factors were also performed. After a median follow-up of approximately 13 years, 28,662 individuals had developed hypertension (N = 27,624) and/or MASLD (N = 1,692). Low body size in childhood increased the risk of adulthood hypertension and MASLD, regardless of adult body size. Individuals with low child body size and high adult body size exhibited the highest risk for both hypertension (HR 2.01, P < 0.001) and MASLD (HR 3.28, P < 0.001). Individuals who had high child body size but average body size in adulthood had risks of the two diseases that were similar to those of persons who had an average body size consistently (all P > 0.05). Body size changes influenced hypertension through significant natural direct effects and indirect effects via anthropometric and metabolic factors, while their impact on MASLD was primarily mediated by these factors without significant direct effects. Childhood leanness exacerbates the risk of hypertension and MASLD in adulthood. Within the follow-up period, normal adult body size would mitigate the detrimental effects of childhood obesity. Thus, attention should be given to reinforcing weight management in children by implementing evidence-based strategies.Keywords
This publication has 60 references indexed in Scilit:
- Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseasesJournal of Hepatology, 2024
- Child-to-adult body size change and risk of type 2 diabetes and cardiovascular diseaseDiabetologia, 2023
- Liver endothelial cells in NAFLD and transition to NASH and HCCCellular and Molecular Life Sciences, 2023
- Ambient air pollution and incidence, progression to multimorbidity and death of hypertension, diabetes, and chronic kidney disease: A national prospective cohortScience of The Total Environment, 2023
- Associations of muscle mass and grip strength with severe NAFLD: A prospective study of 333,295 UK Biobank participantsJournal of Hepatology, 2022
- Overexpression of PDE4D in mouse liver is sufficient to trigger NAFLD and hypertension in a CD36-TGF-β1 pathway: therapeutic role of roflumilastPharmacological Research, 2022
- Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus StatementHepatology, 2021
- Changes in fat mass and fat-free-mass are associated with incident hypertension in four population-based studies from GermanyInternational Journal of Cardiology, 2019
- Adipose tissue plasticity: how fat depots respond differently to pathophysiological cuesDiabetologia, 2016
- Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up studyMetabolism, 2008